In early comparisons, a leading dual-receptor peptide reduced body weight by about 20%, which is already a massive effect
And if we dont address whats underneath the weight gain in the first place, were setting people up for frustration down the road
In both cases, symptoms improved after the medication was discontinued
How these medications cause weight loss when combined is still somewhat of a mystery, but experts theorize that the combo touches the brains reward centers: Bupropion affects the pathways of two neurotransmitters, dopamine and norepinephrine, which are used in brain areas that process appetite and reward, and naltrexone tends to boost and reinforce this effect, Maselli says
Step 2: Provider Review A licensed healthcare provider reviews your assessment
TGA Status, Research Use & Sourcing 7 min read Retatrutide vs Tirzepatide Australia: Triple vs Dual Agonist Research Comparison 8 min read Retatrutide Statistics 2026: Trial Numbers, Dose-Cohort Data & Phase 3 Enrollment 13 min read Retatrutide Research in Australia: 2026 Annual Report 14 min read Retatrutide Research Papers: Primary Source Index 2026 8 min read Retatrutide FAQ: 50 Research Questions Answered 18 min read Retatrutide TRIUMPH-1 Results (2026): What the Phase 3 Data Showed 9 min read